Journal
THROMBOSIS JOURNAL
Volume 21, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12959-023-00462-x
Keywords
Lower extremity deep vein thrombosis; LINC00659; FGF1; DNMT3A
Categories
Ask authors/readers for more resources
It has been shown that long non-coding RNA (lncRNA) LINC00659 is upregulated in the peripheral blood of patients with deep venous thrombosis (DVT). This study aims to investigate the function of LINC00659 in lower extremity DVT (LEDVT). The results demonstrated that LINC00659 is upregulated in IVC tissues and isolated EPCs of patients with LEDVT, and its knock-down promotes EPC proliferation, migration, and angiogenesis ability.
It has been shown that long non-coding RNA (lncRNA) LINC00659 was markedly upregulated in the peripheral blood of patients with deep venous thrombosis (DVT). However, the function of LINC00659 in lower extremity DVT (LEDVT) remains to be largely unrevealed. A total of 30 inferior vena cava (IVC) tissue samples and peripheral blood (60 ml per subject) were obtained from LEDVT patients (n = 15) and healthy donors (n = 15), and then LINC00659 expression was detected by RT-qPCR. The results displayed that LINC00659 is upregulated in IVC tissues and isolated endothelial group cells (EPCs) of patients with LEDVT. LINC00659 knock-down promoted the proliferation, migration, and angiogenesis ability of EPCs, while an pcDNA-eukaryotic translation initiation factor 4A3 (EIF4A3), a EIF4A3 overexpression vector, or fibroblast growth factor 1 (FGF1) small interfering RNA (siRNA) combined with LINC00659 siRNA could not enhance this effect. Mechanistically, LINC00659 bound with EIF4A3 promoter to upregulated EIF4A3 expression. Besides, EIF4A3 could facilitate FGF1 methylation and its downregulated expression by recruiting DNA methyltransferases 3A (DNMT3A) to the FGF1 promoter region. Additionally, LINC00659 inhibition could alleviate LEDVT in mice. In summary, the data indicated the roles of LINC00659 in the pathogenesis of LEDVT, and the LINC00659/EIF4A3/FGF1 axis could be a novel therapeutic target for the treatment of LEDVT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available